Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.

NCT00348504 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1300

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Heart Failure

Interventions

DRUG: levosimendan
DRUG: dobutamine

Sponsor

Abbott

Collaborators

[object Object]